
Genesis IBRC India Ltd is Rated Sell
2026-05-31 10:10:04Genesis IBRC India Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 27 Jan 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 31 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Genesis IBRC India Ltd is Rated Sell
2026-05-20 10:10:03Genesis IBRC India Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 27 Jan 2026. However, all fundamentals, returns, and financial metrics discussed here reflect the stock's current position as of 20 May 2026, providing investors with an up-to-date analysis of the company’s standing.
Read full news article
Genesis IBRC India Ltd Sees Bullish Technical Shift Amid Mixed Price Momentum
2026-05-12 08:00:58Genesis IBRC India Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has recently exhibited a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. Despite a 5.00% decline in the latest trading session, the stock’s technical indicators such as MACD, moving averages, and Bollinger Bands suggest an improving outlook, contrasting with its current Mojo Grade of Sell.
Read full news article
Genesis IBRC India Ltd is Rated Sell
2026-05-09 10:10:03Genesis IBRC India Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 27 Jan 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 May 2026, providing investors with an up-to-date view of the company's fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Genesis IBRC India Ltd is Rated Sell
2026-04-28 10:10:03Genesis IBRC India Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 27 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 April 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Genesis IBRC India Ltd is Rated Sell
2026-04-17 10:10:40Genesis IBRC India Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 27 January 2026. However, all fundamentals, returns, and financial metrics discussed here reflect the stock's current position as of 17 April 2026, providing investors with an up-to-date analysis of the company’s standing.
Read full news article
Genesis IBRC India Ltd is Rated Sell
2026-04-06 10:10:03Genesis IBRC India Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 27 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 April 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.
Read full news article
Genesis IBRC India Ltd is Rated Sell
2026-03-26 10:10:02Genesis IBRC India Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 27 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 March 2026, providing investors with the most up-to-date view of the company's performance and outlook.
Read full news article
Genesis IBRC India Ltd is Rated Sell
2026-03-13 10:10:29Genesis IBRC India Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 27 Jan 2026. However, all fundamentals, returns, and financial metrics discussed here reflect the stock's current position as of 13 March 2026, providing investors with an up-to-date analysis of the company’s standing.
Read full news articleCompliances-Reg.24(A)-Annual Secretarial Compliance
30-May-2026 | Source : BSEAnnual Compliance Audit Report for the financial year ended March 31 2026
Board Meeting Outcome for Outcome Of Board Meeting Held On May 29 2026
29-May-2026 | Source : BSEOutcome of board meeting held on May 29 2026.
Statement Of Deviation For The Quarter And Financial Year Ended March 31 2026
29-May-2026 | Source : BSEStatement of deviation for the quarter and financial year ended March 31 2026
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available






